Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease ...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

This Fool wants to make the most of the benefits a Stocks and Shares ISA provides. He's keen on these two stocks. The post I ...

AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle. | The FDA signed off on ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the ...

NKT2152, a novel HIF2a inhibitor, demonstrates significant efficacy in patients with advanced clear cell renal cell carcinoma ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

GSK PLC GSK shares slipped 2.45% to £15.36 Friday, on what proved to be an all-around grim trading session for the stock ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

Shields has been vocal about women's wellness and now backs an initiative for women to be aware of an infection that's ...

Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...